‹ Back to the Press Room Frontier Medicines FierceBiotech names Frontier Medicines one of its “Fierce 15” biotech companies of 2019 Frontier Medicines Announces Three Executive Hires: Chief Scientific Officer, Chief Technology Officer & Head of Degrader Technologies Frontier Medicines launches with $67 million to develop novel medicines that drug the “undruggable” targets driving human disease Frontier Medicines – Using Chemoproteomics to Find New Cancer Drug Targets
